http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101290578-B1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-308 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C49-747 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L2-52 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C49-747 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-05 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-045 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
filingDate | 2011-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2013-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2013-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-101290578-B1 |
titleOfInvention | Anticancer composition comprising a hydroxymethoxy benzochalcone compound as an active ingredient |
abstract | The present invention relates to a hydroxymethoxybenzochalcone compound represented by the following Chemical Formula 1 having an effect of inhibiting cell cycle progression and cell growth ability by increasing the amount of cell cycle progression inhibiting protein p21 and an anticancer composition comprising the same. . [Formula 1] Hydroxymethoxybenzochalcone compound according to the present invention has excellent anticancer effect through the overexpression of p21 can be usefully used as a cancer prevention and treatment agent. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101821498-B1 |
priorityDate | 2011-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 229.